peb 3rd us provider signed for cxbladder, page-8

Yep Sarto....that's it

but just remember it does not include Europe, China, Japan, Korea, India, Indonesia or Iceland ???

and it does not include Quest Celera's test for Lung Cancer

and it does not include the range of other diagnostic tests under collaboration.

and it does not include the potential therapeutic market

and it does not include the "hair" stuff with world wide distribution.

start crunching the Nos on this and a 10+ bagger seems pretty reasonable in the medium - 5 years term.

GLTA